LOS ANGELES, CA — (Marketwired) — 07/06/17 — US Nuclear Corp. (OTCBB: UCLE) was recently awarded a $722,500 contract to supply the U.S. Air Force with a new fleet of portable Tritium air monitors, bringing their current order back-log up to $2.4 million. The new monitors will replace the fleet of obsolete instruments currently being used. Sandia National Laboratories was enlisted to help the USAF in testing and selecting an appropriate replacement model, and after several years of deliberati
After one of the biggest equipment upgrades in the history of broadcasting in Germany, regular operation of DVB-T2 HD started on schedule this year. ZDF, the largest public broadcaster in Germany, selected the R&S AVHE100 encoding and multiplexing solution from Rohde & Schwarz with HEVC technology from the Fraunhofer HHI for its headend implementation. The transition to DVB-T2, including switching off DVB-T, was accomplished without a single hitch in just one night.
The Rohde &a
VALENCIA, SPAIN — (Marketwired) — 07/05/17 — Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infa
The ElasTest project, with an 5M of EU funding under the Research and Innovation action from the Horizon 2020 program kicked-off in January 2017. Partners from academia, research institutions and IT companies are working together with the overall aim to offer an elastic platform for testing complex distributed large software systems to help end-to-end testing.
The goal of the ElasTest project is to increase software quality by reducing the complexity of software testing on large distributed sy
Effects a public listing of an autoimmune biotechnology company with its first drug expected to enter Phase 3 trials in late 2017 for celiac disease with pivotal data expected by first half 2019; Ulcerative colitis phase 2 clinical trials for INN-108 expected to begin in first half 2018
Canon, AXIS and Milestone join forces to present innovative imaging technology and analytics solutions for combating security challenges to foster smart and safe cities
Birmingham, UK, June 30, 2017 – (ACN Newswire) – Suprema Inc., a leading global provider of biometrics and security solutions, today announced that the company will showcase the company–s latest range of biometric security solutions at Security Twenty 17 North at Harrogate, on July 4. At the show, Suprema will showcase its latest facial recognition access control terminal, 2nd generation fingerprint IP readers and security platform.
Introduced at last week–s IFSEC International 2017 exhibitio
